Juvenile Arthritis Functional Assessment Report (JAFAR)
Juvenile Arthritis Functional Assessment Report · Also known as: JAFAR, Juvenile Arthritis Functional Assessment Scale
The JAFAR is a parent-report instrument developed by Lovell et al. in 1989 to assess functional ability in children and adolescents with juvenile idiopathic arthritis (JIA). Measuring across multiple domains including lower extremity function, upper extremity function, and activities of daily living, the JAFAR quantifies the extent to which arthritis and its treatment affect the child's mobility, self-care, and participation in age-appropriate activities. It remains a standard functional outcome measure in pediatric rheumatology research and clinical practice.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
The JAFAR is indicated for children and adolescents aged 3–18 years with juvenile idiopathic arthritis (any subtype or number of joints). It is particularly valuable in pediatric rheumatology clinics for routine functional monitoring, in clinical trials evaluating disease-modifying antirheumatic drugs (DMARDs) or biologic therapies, in physical therapy outcome measurement, and in longitudinal follow-up to track functional trajectory and predict outcomes. The JAFAR is not appropriate for children without arthritis or for non-inflammatory joint conditions.
Strengths & limitations
- Concrete, observable assessment of functional ability rather than subjective well-being; parent can directly observe or reliably report child's actual performance in functional tasks.
- Multi-domain structure captures different functional systems (lower extremity, upper extremity, self-care), identifying disease-specific impacts and informing targeted rehabilitation.
- Highly sensitive to changes in disease activity and treatment response; improvements in inflammation directly translate to measurable functional gains.
- Extensively used in pediatric rheumatology research and clinical practice; decades of validation and data enabling meaningful comparisons across studies.
- Parent-reported design appropriate for young children who cannot reliably self-report; reduces burden of literacy and abstract thinking required for self-report.
- Directly relevant to core outcomes in pediatric rheumatology (functional status is a primary concern for families with JIA).
- Parent-report bias: Parents may overestimate or underestimate their child's abilities depending on their own anxiety, expectations, or knowledge of functional capacity.
- No established MCID; clinically meaningful change must be inferred from expert judgment or estimated from related instruments.
- Does not directly measure pain or disease activity; functional limitation may not always reflect current inflammation (contractures from past inflammation may limit function even with good current disease control).
- Limited information on how JAFAR scores correlate with patient-reported outcomes or quality of life; functional ability and perceived quality of life are related but distinct constructs.
- Validated primarily for JIA; use in other childhood arthropathies (e.g., viral arthritis, Lyme disease) has not been extensively studied.
Frequently asked
What functional domains does the JAFAR measure?
The JAFAR typically assesses Lower Extremity Function (walking, stair climbing, running, jumping), Upper Extremity Function (reaching, grasping, fine motor), and Activities of Daily Living (self-feeding, dressing, hygiene). The exact domains may vary slightly depending on the JAFAR version. Together, these domains capture the major functional impacts of JIA.
Is the JAFAR scored using a simple sum or a more complex algorithm?
The JAFAR uses simple summing: items within each domain are summed to create domain scores. No weighted algorithms or complex transformations are applied. This simplicity makes it practical for clinic use and transparent in interpretation.
What constitutes a clinically meaningful improvement in JAFAR scores?
There is no published MCID for the JAFAR. Based on clinical experience and related functional measures, improvements of 3–5 points per domain are often considered meaningful. However, clinical meaningfulness should also be contextualized to the child's baseline and clinical situation (e.g., a child with very limited baseline function may show meaningful improvement with smaller numerical gains).
Can I use the JAFAR to compare two different children's functional status?
The JAFAR is designed for intra-individual assessment (tracking one child over time), not for inter-individual comparison. Different children may have different baseline function due to disease duration, severity, or residual damage; comparing absolute JAFAR scores between two children without understanding their individual baseline and disease context can be misleading. Use the JAFAR primarily to track change within individual children.
Sources
- Lovell, D. J., Howe, S., Shear, E., Hartner, S., McGirr, G., Schulte, M., & Jaffe, R. (1989). Development of a disability measurement tool for juvenile rheumatoid arthritis. Arthritis & Rheumatism, 32(11), 1390-1395. link ↗
- Lovell, D. J., Giannini, E. H., & Reiff, A. (1994). Etanercept in children with polyarticular juvenile rheumatoid arthritis. New England Journal of Medicine, 342(11), 763-769. link ↗
How to cite this page
ScholarGate. (2026, June 3). Juvenile Arthritis Functional Assessment Report. ScholarGate. https://scholargate.app/en/pediatric-medicine/juvenile-arthritis-parent-assessment
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- CHQPediatric Medicine↔ compare
- PAQLQPediatric Medicine↔ compare
- PedsQL Diabetes ModulePediatric Medicine↔ compare
- QOLCEPediatric Medicine↔ compare